Concord Medical Services Holdings Limited (CCM)
NYSE: CCM · Real-Time Price · USD
5.29
+0.04 (0.76%)
Aug 21, 2026, 4:00 PM EDT - Market closed
CCM Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 460.51 | 383.96 | 537.4 | 472.09 | 485.63 | |
Revenue Growth | 19.94% | -28.55% | 13.84% | -2.79% | 117.76% |
Cost of Revenue | 434.69 | 463.12 | 614.01 | 624.49 | 542.53 |
Gross Profit | 25.82 | -79.16 | -76.61 | -152.41 | -56.9 |
Selling, General & Admin | 265.15 | 453 | 386.38 | 372.64 | 401.42 |
Operating Expenses | 265.15 | 453 | 386.38 | 372.64 | 401.42 |
Operating Income | -239.33 | -532.16 | -462.99 | -525.05 | -458.32 |
Interest Expense | -152.33 | -193.2 | -165.67 | -120.36 | -73.79 |
Interest & Investment Income | 9.68 | 13.98 | 10.83 | 10.02 | 5.89 |
Earnings From Equity Investments | 13.05 | 12.7 | 20.79 | 17.65 | 18.16 |
Currency Exchange Gain (Loss) | -12.04 | -17.47 | 10.15 | 54.98 | -19.93 |
Other Non Operating Income (Expenses) | -7.7 | -9.1 | -5.57 | -11.35 | -1.26 |
EBT Excluding Unusual Items | -388.67 | -725.25 | -592.45 | -574.1 | -529.24 |
Gain (Loss) on Sale of Investments | 15.31 | 7.17 | 37.5 | - | - |
Gain (Loss) on Sale of Assets | - | 48.5 | -0.64 | -61.55 | - |
Other Unusual Items | - | - | - | -204.25 | - |
Pretax Income | -373.36 | -669.58 | -555.59 | -839.9 | -529.24 |
Income Tax Expense | 6.06 | -17.51 | -24.57 | -70.91 | -6.57 |
Earnings From Continuing Operations | -379.42 | -652.08 | -531.02 | -768.99 | -522.67 |
Minority Interest in Earnings | 286.61 | 343.83 | 233.36 | 279.33 | 251.25 |
Net Income | -92.81 | -308.24 | -297.66 | -489.66 | -271.43 |
Preferred Dividends & Other Adjustments | - | - | - | - | 549.19 |
Net Income to Common | -92.81 | -308.24 | -297.66 | -489.66 | -820.62 |
Net Income Growth | - | - | - | - | - |
Shares Outstanding (Basic) | 4 | 4 | 4 | 4 | 4 |
Shares Outstanding (Diluted) | 4 | 4 | 4 | 4 | 4 |
Shares Change | - | - | - | - | - |
EPS (Basic) | -21.25 | -70.56 | -68.14 | -112.09 | -187.85 |
EPS (Diluted) | -21.25 | -70.56 | -68.14 | -112.09 | -187.85 |
EPS Growth | - | - | - | - | - |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -293.13 | -798.42 | -392.17 | -600.47 | -1,120 |
Free Cash Flow Per Share | -67.10 | -182.77 | -89.77 | -137.46 | -256.36 |
Gross Margin | 5.61% | -20.62% | -14.26% | -32.28% | -11.72% |
Operating Margin | -51.97% | -138.60% | -86.15% | -111.22% | -94.38% |
Profit Margin | -20.15% | -80.28% | -55.39% | -103.72% | -168.98% |
Free Cash Flow Margin | -63.65% | -207.95% | -72.98% | -127.19% | -230.60% |
EBITDA | -99.7 | -411.03 | -344.16 | -401.86 | -363.86 |
EBITDA Margin | -21.65% | -107.05% | -64.04% | -85.13% | -74.92% |
D&A For EBITDA | 139.63 | 121.13 | 118.83 | 123.19 | 94.46 |
EBIT | -239.33 | -532.16 | -462.99 | -525.05 | -458.32 |
EBIT Margin | -51.97% | -138.60% | -86.15% | -111.22% | -94.38% |
Revenue as Reported | 460.51 | 383.96 | 537.4 | 472.09 | 485.63 |